Canada Gazette, Part I, Volume 147, Number 38: GOVERNMENT NOTICES

September 21, 2013

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Significant New Activity Notice No. 11489a (variation to Significant New Activity Notice No. 11489)

Significant New Activity Notice

(Section 85 of the Canadian Environmental Protection Act, 1999)

Whereas the Minister of the Environment and the Minister of Health have assessed information in respect of the substance silane, triethoxy(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)-, Chemical Abstracts Service Registry Number 51851-37-7, under section 83 of the Canadian Environmental Protection Act, 1999;

Whereas the Minister of the Environment published on January 28, 2006, Significant New Activity Notice No. 11489 in Part Ⅰ of the Canada Gazette, Vol. 140, No. 4;

Whereas the substance is not specified on the Domestic Substances List;

And whereas the ministers suspect that a significant new activity in relation to the substance may result in the substance becoming toxic within the meaning of section 64 of the Canadian Environmental Protection Act, 1999,

Therefore, the Minister of the Environment hereby varies Significant New Activity Notice No. 11489, pursuant to subsection 85(2) of the Canadian Environmental Protection Act, 1999, in accordance with the following Annex.

LEONA AGLUKKAQ
Minister of the Environment

ANNEX

1. Significant New Activity Notice No. 11489 is replaced by the following:

ANNEX

Information Requirements
(Section 85 of the Canadian Environmental Protection Act, 1999)

  1. In relation to the substance silane, triethoxy (3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)-, a significant new activity is the use of the substance in Canada, in any quantity, other than its use as an industrial or commercial surface modification agent or as an industrial or commercial adhesion promoter between inorganic materials and fluoropolymers.
  2. Despite item 1, the use of the substance as a research and development substance, a site-limited intermediate substance or a contained substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), is not a new activity.
  3. The following information must be provided to the Minister, at least 90 days before the commencement of each proposed significant new activity:
    • (a) a description of the proposed significant new activity in relation to the substance;
    • (b) the information specified in Schedule 4 to the New Substances Notification Regulations (Chemicals and Polymers);
    • (c) the information specified in item 8 of Schedule 5 to those Regulations;
    • (d) the information specified in item 11 of Schedule 6 to those Regulations;
    • (e) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
    • (f) the identification of every government department or government agency, either outside or within Canada, to which the person proposing the significant new activity has provided information regarding the use of the substance and if known, the department’s or agency’s file number and if any, the outcome of the department’s or agency’s assessment and risk management actions in relation to the substance imposed by the department or agency;
    • (g) if known, the three sites in Canada where the greatest quantity of the substance, in relation to the significant new activity, is anticipated to be used or processed and the estimated quantity by site;
    • (h) the test data and a test report from a 28-day repeated dose inhalation toxicity study in respect of the substance, conducted according to the methodology described in the Organisation for Economic Co-operation and Development (OECD) Test Guideline No. 412 titled Subchronic Inhalation Toxicity: 28-day Study, and in conformity with practices described in the OECD Principles of Good Laboratory Practice (“Principles of GLP”) set out in Annex 2 of the Decision of the Council Concerning the Mutual Acceptance of Data in the Assessment of Chemicals, adopted on May 12, 1981. Both the OECD Test Guideline and Principles of GLP must be current at the time of the test; and
    • (i) all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they have access, and that are relevant to determining whether the substance is toxic or capable of becoming toxic.
  4. The above information will be assessed within 90 days after the day on which it is received by the Minister.

EXPLANATORY NOTE

(This explanatory note is not part of the Significant New Activity Notice.)

A Significant New Activity Notice is a legal instrument issued by the Minister of the Environment pursuant to section 85 of the Canadian Environmental Protection Act, 1999. The Significant New Activity Notice sets out the appropriate information that must be provided to the Minister for assessment prior to the commencement of a new activity as described in the Notice.

Substances that are not listed on the Domestic Substances List can be manufactured or imported only by the person who has met the requirements set out in section 81 of the Canadian Environmental Protection Act, 1999. Under section 86 of the Canadian Environmental Protection Act, 1999, in circumstances where a Significant New Activity Notice is issued for a new substance, it is the responsibility of every person who transfers the physical possession or control of the substance to notify all persons to whom the possession or control is transferred of the obligation to comply with the Significant New Activity Notice and of the obligation to notify the Minister of the Environment of any new activity and all other information as described in the Notice. It is the responsibility of the users of the substance to be aware of and comply with the Significant New Activity Notice and to submit a Significant New Activity notification to the Minister prior to the commencement of a significant new activity associated with the substance. However, as mentioned in subsection 81(6) of the Canadian Environmental Protection Act, 1999, a Significant New Activity notification is not required when the proposed new activity is regulated under an act or regulations listed on Schedule 2 to the Canadian Environmental Protection Act, 1999.

A Significant New Activity Notice does not constitute an endorsement from Environment Canada or the Government of Canada of the substance to which it relates, or an exemption from any other laws or regulations that are in force in Canada and that may apply to this substance or activities involving the substance.

[38-1-o]

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Significant New Activity Notice No. 15441

Rescinding Significant New Activity Notice

(Section 85 of the Canadian Environmental Protection Act, 1999)

Whereas the Minister of the Environment has previously imposed Significant New Activity Notice No. 15441 pertaining to the substance 2-Propenoic acid, 2-methyl-, methyl ester, polymer with hydrolyzed poly(vinyl acetate) and polyfluorooctyl acrylate, on April 18, 2009;

Whereas the Minister of the Environment and the Minister of Health have assessed additional information pertaining to the substance;

And whereas the ministers no longer suspect that a significant new activity in relation to the substance may result in the substance becoming toxic within the meaning of section 64 of the Canadian Environmental Protection Act, 1999,

Therefore, the Minister of the Environment hereby indicates pursuant to subsection 85(2) that subsection 81(4) of the Canadian Environmental Protection Act, 1999 no longer applies to the substance and rescinds Significant New Activity Notice No. 15441.

LEONA AGLUKKAQ
Minister of the Environment

[38-1-o]

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Significant New Activity Notice No. 16138

Rescinding Significant New Activity Notice

(Section 85 of the Canadian Environmental Protection Act, 1999)

Whereas the Minister of the Environment has previously imposed Significant New Activity Notice No. 16138 pertaining to the substance 2-Propenoic acid, 2-methyl-, 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl ester, polymer with 1,1-dichloroethene and alkyl 2-propenoate, on December 25, 2010;

Whereas the Minister of the Environment and the Minister of Health have assessed additional information pertaining to the substance;

And whereas the ministers no longer suspect that a significant new activity in relation to the substance may result in the substance becoming toxic within the meaning of section 64 of the Canadian Environmental Protection Act, 1999,

Therefore, the Minister of the Environment hereby indicates pursuant to subsection 85(2) that subsection 81(4) of the Canadian Environmental Protection Act, 1999 no longer applies to the substance and rescinds Significant New Activity Notice No. 16138.

LEONA AGLUKKAQ
Minister of the Environment

[38-1-o]

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Significant New Activity Notices Nos. 14888, 15312, 15313, 15314, 15315, 16266, 16267 and 16268

Rescinding Significant New Activity Notices

(Section 85 of the Canadian Environmental Protection Act, 1999)

Whereas the Minister of the Environment has previously imposed the Significant New Activity notices mentioned in the Annex;

Whereas the Minister of the Environment and the Minister of Health have assessed additional information pertaining to the substances concerned by these Significant New Activity notices;

And whereas the ministers no longer suspect that a significant new activity in relation to the substances may result in the substances becoming toxic within the meaning of section 64 of the Canadian Environmental Protection Act, 1999,

Therefore, the Minister of the Environment hereby indicates pursuant to subsection 85(2) that subsection 81(4) of the Canadian Environmental Protection Act, 1999 no longer applies to the substances and rescinds the Significant New Activity notices mentioned in the Annex.

LEONA AGLUKKAQ
Minister of the Environment

ANNEX

  1. Significant New Activity Notice No. 14888 pertaining to the substance Siloxanes and Silicones, substituted alkyl Me, di-Me, Me substituted alkyl, polymers with stearyl acrylate, polyfluoro methacrylate and vinyl chloride, published on December 1, 2007, in Part Ⅰ of the Canada Gazette, Vol. 141, No. 48.
  2. Significant New Activity Notice No. 15312 pertaining to the substance 2-Propenoic acid, 2-hydroxyethyl ester, telomer with 2-mercaptoethanol, polyalkyleneglycol acrylate, polyalkyleneglycol polyacrylate and 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl 2-propenoate, published on November 29, 2008, in Part Ⅰ of the Canada Gazette, Vol. 142, No. 48.
  3. Significant New Activity Notice No. 15313 pertaining to the substance 2-Propenoic acid, 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl ester, polymer with polyalkyleneglycol acrylate, published on November 29, 2008, in Part Ⅰ of the Canada Gazette, Vol. 142, No. 48.
  4. Significant New Activity Notice No. 15314 pertaining to the substance Polyfluoro acrylate, polymer with chloroethene, published on November 29, 2008, in Part Ⅰ of the Canada Gazette, Vol. 142, No. 48.
  5. Significant New Activity Notice No. 15315 pertaining to the substance Polyfluoro acrylate, polymer with chloroethene, published on November 29, 2008, in Part Ⅰ of the Canada Gazette, Vol. 142, No. 48.
  6. Significant New Activity Notice No. 16266 pertaining to the substance 2-Propenoic acid, 2-methyl-, 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl ester, telomer with 1-dodecanethiol and octadecyl 2-propenoate, Chemical Abstracts Service Registry No. 1259487-19-8, published on May 14, 2011, in Part Ⅰ of the Canada Gazette, Vol. 145, No. 20.
  7. Significant New Activity Notice No. 16267 pertaining to the substance 2-Propenoic acid, 2-methyl-, polymer with 2-hydroxyethyl 2-methyl-2-propenoate, α-(1-oxo-2-propen-1-yl)-ω-hydroxypoly (oxy-1,2-ethanediyl) and 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl 2-propenoate, sodium salt, Chemical Abstracts Service Registry No. 1158951-86-0, published on April 30, 2011, in Part Ⅰ of the Canada Gazette, Vol. 145, No. 18.
  8. Significant New Activity Notice No. 16268 pertaining to 2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester, polymer with 1-ethenyl-2-pyrrolidinone, 2-propenoic acid and 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl 2-propenoate, sodium salt, Chemical Abstracts Service Registry No. 1206450-10-3, published on April 30, 2011, in Part Ⅰ of the Canada Gazette, Vol. 145, No. 18.

[38-1-o]

DEPARTMENT OF HEALTH

HAZARDOUS MATERIALS INFORMATION REVIEW ACT

Decisions, undertakings and orders on claims for exemption

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Workplace Hazardous Materials Directorate hereby gives notice of the decisions of the screening officer, respecting each claim for exemption and the relevant material safety data sheet (MSDS) and (where applicable) the label, listed below.

In accordance with section 20 of the Hazardous Materials Information Review Act, a claimant or any affected party may appeal a decision or order of a screening officer. An affected party may also appeal an undertaking in respect of which a notice has been published in the Canada Gazette. “Affected party” means a person who is not a competitor of the claimant and who uses, supplies or is otherwise involved in the use or supply of the controlled product at a work place, and includes

  • (a) a supplier of the controlled product;
  • (b) an employee at the work place;
  • (c) an employer at the work place;
  • (d) a safety and health professional for the work place;
  • (e) a safety and health representative or a member of a safety and health committee for the work place; and
  • (f) a person who is authorized in writing to represent
    • (i) a supplier referred to in paragraph (a) or an employer referred to in paragraph (c), or
    • (ii) an employee referred to in paragraph (b), except where that person is an official or a representative of a trade union that is not certified or recognized in respect of the work place.

To initiate the appeal process, a Statement of Appeal (Form 1) as prescribed by the Hazardous Materials Information Review Act Appeal Board Procedures Regulations must be completed and delivered, along with the fee prescribed by section 12 of the Hazardous Materials Information Review Regulations, within 45 days of the publication of this notice in the Canada Gazette, Part Ⅰ, to the Chief Appeals Officer at the following address: Workplace Hazardous Materials Directorate, 427 Laurier Avenue W, 7th Floor, Ottawa, Ontario K1A 0K9.

STEPHANIE REID
Chief Screening Officer

Claimant Product Identifier (As shown on the MSDS) Registry Number MSDS Preparation Date (As shown on the MSDS) Date of Decision
Ashland Canada Corp., Mississauga, Ontario Presstige ® FB9170 Felt Cleaning and Conditioning Agent 8073 01/05/2011 November 26, 2012
Carolina Biological Supply Company, Burlington, North Carolina Carolina’s Perfect Solution ® Concentrate 8100 02/10/2011 February 6, 2013
UNIVAR Canada Ltd., Richmond, British Columbia ETHOX 4180 8124 17 January 2011 October 15, 2012
Purifics ES Inc., London, Ontario ADX 8139 6-Apr-11 October 22, 2012
Engenium Chemical Corporation,* Calgary, Alberta * formerly Brine-Add Fluids Ltd., Calgary, Alberta ONYXMUL S 8158 April 5, 2011 October 18, 2012
Weatherford Engineered Chemistry Canada Limited, Edmonton, Alberta Smart Frac 8173 March 14, 2011 January 8, 2013
Weatherford Engineered Chemistry Canada Ltd., Edmonton, Alberta AXE 707C 8181 September 9, 2008 January 8, 2013
Stepan Company, Northfield, Illinois AGENT 3109-6 8184 03-23-2011 October 16, 2012
3M Canada Company, London, Ontario 3M(TM) SMC/Fiberglass Repair Adhesive-35 PN 08273 Part A 8188 2011/05/03 November 14, 2012
3M Canada Company, London, Ontario 3M™ SCREEN PRINTING UV INK SERIES 9861 LIGHT GREEN 8211 2011/10/05 October 31, 2012
3M Canada Company, London, Ontario 9875 Process Cyan 8212 2011/10/05 October 31, 2012
3M Canada Company, London, Ontario 3M ™ SCREEN PRINTING UV INK SERIES 9879 BLUE (GS) 8213 2011/10/05 October 31, 2012
3M Canada Company, London, Ontario 3M ™ SCREEN PRINTING UV INK 9882 TRANSPARENT BLUE 8214 2011/10/05 October 31, 2012
3M Canada Company, London, Ontario 3M™ SCREEN PRINTING UV INK SERIES 9891 BLUE VIOLET 8215 2011/10/05 October 31, 2012
3M Canada Company, London, Ontario 3M (TM) 227 PURPLE TRANSPARENT OFFSET INK 8246 2011/06/07 February 15, 2013
Milacron Marketing Company LLC, Cincinnati, Ohio CIMPERIAL® 1080CFZ 8247 02-Nov-2011 November 6, 2012
Canyon Technical Services, Calgary, Alberta CAN-1200 8251 6/29/2011 December 6, 2012
Canyon Technical Services, Calgary, Alberta CAN-1203 8253 6/29/2011 December 6, 2012
3M Canada Company, London, Ontario 3M (TM )SCOTCHLITE (TM) TRANSPARENT SCREEN PRINTING INK 2916 BLUE VIOLET 8254 2011/06/28 February 15, 2013
Momentive Performance Materials, Markham, Ontario SPUR+ 1015 LM Prepolymer Silyated Polyurethane Resin 8257 12/12/2011 March 5, 2013
GE Water & Process Technologies Canada, Oakville, Ontario PROCHEM 3F29 8261 29-SEP-2011 October 31, 2012
BASF Canada Inc., Mississauga, Ontario Dehypound® Advanced 8267 2011/07/09 December 14, 2012
BASF Canada Inc., Mississauga, Ontario Versamine® C39 8270 2011/07/08 December 12, 2012
BASF Canada Inc., Mississauga, Ontario Disponil®AFX 4070 8271 2001/07/08 December 23, 2012
BASF Canada Inc., Mississauga, Ontario Waterpoxy ® 1455 8274 2011/07/08 December 12, 2012
JBI Canada Incorporated, Thorold, Ontario* * formerly Port Robinson, Ontario Marble Traction 8275 May 3, 2011 October 5, 2012
VWR Education LTD., St. Catharines, Ontario Simulated Anti-serum (Anti-A, Anti-B, Anti-RH) 8278 11-July-11 February 13, 2013
VWR Education LTD., St. Catharines, Ontario Simulated Blood (Type A, Type B, Type AB, Type O) 8279 13-July-2011 January 29, 2013
HOUGHTON INTERNATIONAL INC.,* Valley Forge, Pennsylvania * formerly Houghton Canada Inc. HOCUT 4549 8285 8 November 2011 February 14, 2013
Afton Chemical Corporation, Richmond, Virginia HiTEC 485 Performance Additive 8286 8/4/2011 December 19, 2012
Calfrac Well Services Ltd., Calgary, Alberta DWP-123 8293 January 14, 2011 October 23, 2012
Calfrac Well Services Ltd., Calgary, Alberta DWP-213 8296 January 25, 2012 October 9, 2012
Calfrac Well Services Ltd., Calgary, Alberta DWP-938 8298 March 5, 2012 November 22, 2012
Calfrac Well Services Ltd., Calgary, Alberta DWP-948 8299 November 2, 2010 December 6, 2012
Calfrac Well Services Ltd., Calgary, Alberta DWP-949 8300 February 2, 2011 December 6, 2012
Calfrac Well Services Ltd., Calgary, Alberta DAP-401 8302 June 03, 2011 January 28, 2013
Calfrac Well Services Ltd., Calgary, Alberta DWP-601 8303 November 4, 2010 January 28, 2013
Ashland Canada Corp., Mississauga, Ontario ProSoft™ TQ1172 Softener 8306 8/22/2011 December 10, 2012
Taminco Inc., Allentown, Pennsylvania Vantex T 8314 13-Jan-2011 October 19, 2012
Taminco Inc., Allentown, Pennsylvania Advantex 8315 13-Jan-2011 October 19, 2012
Weatherford Engineered Chemistry Canada Ltd., Edmonton, Alberta WSF-100 8320 28/May/2012 January 8, 2013
Win Manuco Ltd., Burlington, Ontario APW 8322 April 16, 2012 November 9, 2012
Baker Petrolite Corp., Sugar Land, Texas CRW9124 CORROSION INHIBITOR 8334 9/20/2011 December 14, 2012
Baker Petrolite Corp., Sugar Land, Texas CGW9994 CORROSION INHIBITOR 8335 9/20/2011 December 18, 2012
Baker Petrolite Corp., Sugar Land, Texas CGW3360 CORROSION INHIBITOR 8336 9/20/2011 December 17, 2012
Chevron Lummus Global, LLC, Richmond, California Chevron ISODEWAXING® Catalyst ICR 424 (AII) 8339 April 26, 2012 December 19, 2012
E.I. du Pont Canada Company, Mississauga, Ontario Capstone® FS-60 Fluorosurfactant 8344 11/14/2011 December 7, 2012
E.I. du Pont Canada Company, Mississauga, Ontario Capstone® FS-61 Fluorosurfactant 8345 11/14/2011 December 7, 2012
3M Canada Company, London, Ontario 3M (TM) General Purpose Cleaner Concentrate (Product No. 8, Twist ’n Fill (TM) System) 8346 2011/10/06 February 15, 2013
Nalco Canada Co., Burlington, Ontario FLEXSORB® SE EC9016A 8348 2011/10/17 October 25, 2012
Nalco Canada Co., Burlington, Ontario EC3081A 8350 2011/10/17 October 10, 2012
GE Water & Process Technologies Canada, Oakville, Ontario Thermoflo 7002 8354 24-OCT-2011 February 21, 2013
Cytec Industries Inc., Woodland Park, New Jersey AERO® MX-5160 Promoter 8358 05/14/2012 December 10, 2012
Cytec Industries Inc., Woodland Park, New Jersey DAPCO ™ 3041FR Self Extinguishing, Composite Bonding Epoxy Adhesive, Part A 8360 10/15/2010 December 10, 2012
BWA Water Additives US LLC, Tucker, Georgia BELCLENE 499 8364 19/10/2011 January 10, 2013
BWA Water Additives US LLC, Tucker, Georgia BELLASOL S60 8365 19/10/2011 October 9, 2012
Pulcra Chemicals, LLC, Rock Hill, South Carolina KATAX 6760L 8366 08/23/2012 November 16, 2012
Power Service Product Inc., Weatherford, Texas CLEAR-DIESEL FUEL AND TANK CLEANER, CONCENTRATED FORMULA 8369 April 15, 2011 November 22, 2012
Power Service Product Inc., Weatherford, Texas CLEAR-DIESEL FUEL AND TANK CLEANER 8370 April 15, 2011 October 30, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer CFT 1900 8387 10/4/2012 November 13, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer CFT 2000 8388 10/4/2012 November 13, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer CFT 2100 8389 10/4/2012 November 13, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer CFT 2200 8390 10/4/2012 November 13, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer CFT2400 8391 10/4/2012 November 13, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer CFT 2500 8392 10/4/2012 November 13, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer IWT 1000 8393 10/4/2012 November 13, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer IWT 1100 8394 10/4/2012 November 13, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer IWT 1200 8395 10/4/2012 November 13, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer IWT 1300 8396 10/4/2012 November 13, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer IWT 1400 8397 10/4/2012 November 13, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer IWT 1500 8398 10/4/2012 November 13, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer IWT 1600 8399 10/4/2012 December 7, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer IWT 1700 8400 10/4/2012 December 7, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer IWT 1800 8401 10/4/2012 December 7, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer IWT 1900 8402 10/4/2012 December 7, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer IWT 2000 8403 10/4/2012 December 7, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer IWT 2100 8404 10/4/2012 December 7, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer IWT 2200 8405 10/4/2012 December 7, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer IWT 2400 8406 10/4/2012 December 7, 2012
Core Laboratories, Houston, Texas Spectrachem® Tracer IWT 2500 8407 10/4/2012 December 7, 2012
Afton Chemical Corporation, Richmond, Virginia HiTEC 8888F Performance Additive 8408 11/18/2011 January 31, 2013
Cytec Industries Inc., Woodland Park, New Jersey HT® 424 Thixotropic Paste, Part A 8412 12/09/2011 October 30, 2012
Momentive Specialty Chemicals, Inc., Oshawa, Ontario Fentak ™ UR0777 8415 08-MAY-2012 December 17, 2012
Momentive Specialty Chemicals, Inc., Oshawa, Ontario Fentak ™ MR0953 8416 08/MAY/2012 February 24, 2013
Trican Well Service Ltd., Calgary, Alberta FA-1 8418 Nov 29, 2011 February 18, 2013
Trican Well Service Ltd., Calgary, Alberta TTA 8419 Nov 29, 2011 March 21, 2013
Baker Petrolite Corporation, Sugar Land, Texas LIFESPAN™ 3500 HEAVY OIL STABILIZER 8423 12/13/2011 January 23, 2013
DuraSystems Barriers Inc., Vaughan, Ontario Type SFI-A Resin 8424 28 May 2012 February 1, 2013
DuraSystems Barriers Inc., Vaughan, Ontario SFI-B Hardener 8425 28 May 2012 February 1, 2013
3M Canada Company, London, Ontario SCOTCHKOTE 6233-4G, 6233-11G FUSION BONDED EPOXY COATING 8426 2011/12/19 March 25, 2013
Oilflow Solutions Inc., Calgary, Alberta SI-101 8427 14th May 2012 November 20, 2012
Sealed Air Corporation, Brampton, Ontario INSTAFILL® COMPONENT “B” 8431 12/20/2011 February 22, 2013
Sealed Air Corporation, Brampton, Ontario INSTAPAK® MOLDING FOAM COMPONENT “B” 8432 12/20/2011 February 22, 2013
Sealed Air Corporation, Brampton, Ontario INSTAFLEX® COMPONENT “B” 8433 12/20/2011 February 22, 2013
Sealed Air Corporation, Brampton, Ontario GFLEX® COMPONENT “B” 8434 12/20/2011 February 22, 2013
Sealed Air Corporation, Brampton, Ontario INSTAPAK® RIGID 125 COMPONENT “B” 8435 12/20/2011 February 22, 2013
Sealed Air Corporation, Brampton, Ontario INSTAPAK® RIGID 150 COMPONENT “B” 8437 12/20/2011 February 22, 2013
Sealed Air Corporation, Brampton, Ontario ULTRALITE® COMPONENT “B” 8438 12/20/2011 March 21, 2013
Sealed Air Corporation, Brampton, Ontario GFLEX® QS-COMPONENT “B” 8439 12/20/2011 March 21, 2013
Sealed Air Corporation, Brampton, Ontario INSTAPAK® RT COMPONENT “B” 8442 12/10/2010 March 21, 2013
G.E. Water & Process Technologies Canada, Oakville, Ontario GENGARD GN8117 8446 18-APR-2012 March 25, 2013
Calfrac Well Services Ltd., Calgary, Alberta DWP-107 8454 December 22, 2011 March 25, 2013
Calfrac Well Services Ltd., Calgary, Alberta DWP-214 8455 December 22, 2011 March 21, 2013
Calfrac Well Services Ltd., Calgary, Alberta DWP-218 8456 December 22, 2011 March 21, 2013
Calfrac Well Services Ltd., Calgary, Alberta DWP-219 8457 December 22, 2011 March 21, 2013
Calfrac Well Services Ltd., Calgary, Alberta DWP-922 8459 December 22, 2011 February 25, 2013
Calfrac Well Services, Calgary, Alberta DAP-925 8462 January 19, 2012 March 21, 2013
Afton Chemical Corporation, Richmond, Virginia ACTRAMIDE 303 8463 1/4/2012 January 31, 2013
Afton Chemical Corporation, Richmond, Virginia HiTEC 6457 Fuel Additive 8465 1/4/2012 January 31, 2013
MeadWestvaco Corporation - Specialty Chemicals Division, North Charleston, South Carolina PAVE ™ 192 8467 6/04/2012 March 14, 2013
Momentive Specialty Chemicals Inc., Oshawa, Ontario EPIKURE™ Curing Agent 3290 8468 29-FEB-2012 December 14, 2012
Momentive Specialty Chemicals Inc., Oshawa, Ontario EPIKURE™ Curing Agent 6870-W-53 8470 07-MAR-2012 January 11, 2013
Baker Petrolite Corp., Sugar Land, Texas RE4267 8483 1/20/2012 December 20, 2012
Baker Petrolite Corp., Sugar Land, Texas CRW9139 CORROSION INHIBITOR 8485 1/26/2012 March 8, 2013
The Lubrizol Corporation, Wickliffe, Ohio POWERZOL(TM) 9541 8487 26 May 2012 January 30, 2013
The Lubrizol Corporation, Wickliffe, Ohio POWERZOL(TM) 9543 8488 26 May 2012 January 30, 2013
The Lubrizol Corporation, Wickliffe, Ohio POWERZOL(TM) 9539 8489 25 May 2012 January 30, 2013
Nalco Canada Co., Burlington, Ontario NALCO® EC3275A 8497 2012/02/14 February 11, 2013
Nalco Canada Co., Burlington, Ontario EC3018A ANTIFOULANT 8499 2012/02/14 January 3, 2013
Nalco Canada Co., Burlington, Ontario NALCO® EC3276A 8501 2012/02/14 February 11, 2013
BASF Canada, Inc., Mississauga, Ontario Plurafac® SLF 18B-45 8504 2012/05/23 October 9, 2012
Baker Petrolite Corp., Sugar Land, Texas CRO396 CORROSION INHIBITOR 8509 2/13/2012 January 11, 2013
The Lubrizol Corporation, Wickliffe, Ohio ALOX® 2100 8517 26 May 2012 December 13, 2012
The Lubrizol Corporation, Wickliffe, Ohio ALOX® 2165 8518 26 May 2012 December 13, 2012
Momentive Performance Materials, Markham, Ontario Niax® catalyst A-31 8521 06/07/2012 March 6, 2013
Momentive Performance Materials, Markham, Ontario Niax® flame lamination additive FLE-220LF 8522 06/07/2012 March 18, 2013
Momentive Performance Materials, Markham, Ontario Niax*catalyst A-440 8523 06/07/2012 February 24, 2013
Nalco Canada Co., Burlington, Ontario NALFLOTE® 9897 8527 2012/03/06 March 12, 2013
Nalco Canada Co., Burlington, Ontario NALCO® DVS4U021 8528 2012/03/06 March 12, 2013
Hydro Technologies (Canada) Inc., Québec, Quebec HY BRITE® WM-5008 8533 29 février 2012 (fr.) January 24, 2013
Baker Petrolite Corp., Sugar Land, Texas TOLAD™ 9702 Additive 8538 2012/07/19 January 14, 2013
Trican Well Service Ltd., Calgary, Alberta SS-4 8540 March 12, 2012 March 21, 2013
The Lubrizol Corporation, Wickliffe, Ohio LUBRIZOL® 9660 8542 30 July 2012 March 20, 2013
The Lubrizol Corporation, Wickliffe, Ohio LUBRIZOL® 9690 8543 23 July 2012 March 20, 2013
Baker Petrolite Corp., Sugar Land, Texas TRETOLITE™ RBW987 REVERSE BREAKER 8577 2012/03/29 February 28, 2013
Wax Busters Ltd., Calgary, Alberta WB-34 8591 April 24, 2012 February 27, 2013
Privista Inc., Overland Park, Kansas Privista Activator 8592 08-May-2012 March 27, 2013
Privista Inc., Overland Park, Kansas Privista Primer 8593 09-Aug-2012 March 27, 2013
BWA Water Additives US LLC, Decatur, Georgia* * formerly Tucker, Georgia DP3562 8625 August 28th, 2012 March 4, 2013
BWA Water Additives US LLC, Decatur, Georgia* * formerly Tucker, Georgia BELCLENE 440 8626 August 30th, 2012 March 14, 2013
E.I. du Pont Canada Company, Mississauga, Ontario Dupont (TM) Cyrel (R) Cylosol Plate Washout Solution 2012 8630 July 5, 2012 January 31, 2013

Notes:

  1. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on March 5, 2011, listed the subject of the claim bearing Registry Number 8100 to be the chemical identity and concentration of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients and concentration of four ingredients.
  2. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on May 21, 2011, listed the subject of the claim bearing Registry Number 8124 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of five ingredients.
  3. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on May 21, 2011, listed the subject of the claim bearing Registry Number 8139 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of four ingredients.
  4. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on May 21, 2011, listed the subject of the claim bearing Registry Number 8188 to be the chemical identity of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
  5. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on May 21, 2011, listed the product identifier bearing Registry Number 8211 to be 3M™ Screen Printing UV Ink Series 9861 Light Green. The product identifier for the product on which the screening officer issued the decision is 3M™ SCREEN PRINTING UV INK SERIES 9861 LIGHT GREEN.
  6. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on May 21, 2011, listed the product identifier bearing Registry Number 8212 to be 3M™ Screen Printing UV Ink Series 9875 Process Cyan. The product identifier for the product on which the screening officer issued the decision is 9875 Process Cyan.
  7. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on May 21, 2011, listed the product identifier bearing Registry Number 8213 to be 3M™ Screen Printing UV Ink Series 9879 Blue (GS). The product identifier for the product on which the screening officer issued the decision is 3M™ SCREEN PRINTING UV INK SERIES 9879 BLUE (GS).
  8. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on May 21, 2011, listed the product identifier bearing Registry Number 8214 to be 3M™ Screen Printing UV Ink Series 9882 Transparent Blue. The product identifier for the product on which the screening officer issued the decision is 3M™ SCREEN PRINTING UV INK 9882 TRANSPARENT BLUE.
  9. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on May 21, 2011, listed the product identifier bearing Registry Number 8215 to be 3M™ Screen Printing UV Ink Series 9891 Blue Violet. The product identifier for the product on which the screening officer issued the decision is 3M™ SCREEN PRINTING UV INK SERIES 9891 BLUE VIOLET.
  10. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 30, 2011, listed the subject of the claim bearing Registry Number 8246 to be the chemical identity of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of six ingredients.
  11. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 30, 2011, listed the product identifier bearing Registry Number 8257 to be SPUR+ 1015 LM Prepolymer. The product identifier for the product on which the screening officer issued the decision is SPUR+ 1015 LM Prepolymer Silyated Polyurethane Resin.
  12. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 30, 2011, listed the product identifier bearing Registry Number 8267 to be DEHYPOUND® ADVANCED. The product identifier for the product on which the screening officer issued the decision is Dehypound® Advanced.
  13. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 30, 2011, listed the product identifier bearing Registry Number 8270 to be VERSAMINE® C39. The product identifier for the product on which the screening officer issued the decision is Versamine® C39.
  14. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 30, 2011, listed the product identifier bearing Registry Number 8271 to be DISPONIL AFX 4070. The product identifier for the product on which the screening officer issued the decision is Disponil® AFX 4070.
  15. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 30, 2011, listed the product identifier bearing Registry Number 8274 to be WATERPOXY® 1455. The product identifier for the product on which the screening officer issued the decision is Waterpoxy® 1455.
  16. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 30, 2011, listed the product identifier bearing Registry Number 8278 to be Simulated Anti-serum. The product identifier for the product on which the screening officer issued the decision is Simulated Anti-serum (Anti-A, Anti-B, Anti-RH).
  17. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on July 30, 2011, listed the product identifier bearing Registry Number 8279 to be Simulated Blood. The product identifier for the product on which the screening officer issued the decision is Simulated Blood (Type A, Type B, Type AB, Type O).
  18. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on September 24, 2011, listed the subject of the claim bearing Registry Number 8286 to be the chemical identity of five ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
  19. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on September 24, 2011, listed the subject of the claim bearing Registry Number 8302 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  20. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on September 24, 2011, listed the subject of the claim bearing Registry Number 8303 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  21. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on September 24, 2011, listed the subject of the claim bearing Registry Number 8320 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of five ingredients.
  22. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on December 3, 2011, listed the subject of the claim bearing Registry Number 8358 to be the chemical identity of five ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
  23. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on December 3, 2011, listed the subject of the claim bearing Registry Number 8360 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  24. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on December 3, 2011, listed the subject of the claim bearing Registry Number 8408 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
  25. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Number 8423 to be the chemical identity of two ingredients and concentration of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients and concentration of three ingredients.
  26. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Number 8424 to be the chemical identity of five ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  27. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Number 8425 to be the chemical identity of six ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
  28. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Number 8439 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.
  29. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Number 8442 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.
  30. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Number 8462 to be the chemical identity and concentration of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  31. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Number 8467 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity and concentration of two ingredients.
  32. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Number 8468 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
  33. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Numbers 8487 and 8488 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
  34. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Number 8497 to be the chemical identity of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.
  35. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on February 18, 2012, listed the subject of the claim bearing Registry Number 8501 to be the chemical identity of five ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.
  36. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on April 28, 2012, listed the product identifier bearing Registry Number 8523 to be Niax® catalyst A-440. The product identifier for the product on which the screening officer issued the decision is Niax* catalyst A-440.
  37. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on April 28, 2012, listed the subject of the claim bearing Registry Number 8527 to be the chemical identity of seven ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of five ingredients.
  38. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on April 28, 2012, listed the subject of the claim bearing Registry Number 8528 to be the chemical identity of seven ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of five ingredients.
  39. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on June 30, 2012, listed the subject of the claim bearing Registry Number 8593 to be the chemical identity of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.
  40. The Notice of Filing published in the Canada Gazette, Part Ⅰ, on June 30, 2012, listed the subject of the claim bearing Registry Number 8625 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.

There were no written representations from affected parties to the screening officer with respect to any of the above-mentioned claims for exemption and related MSDSs or labels.

Each of the claims for exemption listed above was found to be valid. The screening officer reached this decision after reviewing the information in support of the claim, having regard exclusively to the criteria found in section 3 of the Hazardous Materials Information Review Regulations.

Having regard for the various data readily available in the literature and any information provided by the claimant, the screening officer found that the MSDSs in respect of the claims bearing Registry Numbers 8336, 8339, 8387, 8388, 8389, 8390, 8391, 8392, 8431, 8432, 8433, 8434, 8435, 8437, 8438, 8499, 8504, 8533, 8538, 8542, 8543, 8577 and 8625 complied with the applicable requirements of the Hazardous Products Act and the Controlled Products Regulations.

In the case of the claims bearing Registry Numbers 8251 and 8253, being claims from an employer with operations in the province of Alberta, the screening officer found that the MSDSs and labels in respect of which the claims were filed did not comply with the applicable disclosure requirements of the Occupational Health and Safety Code 2009 of the Province of Alberta.

In the case of the claims bearing Registry Numbers 8424 and 8425, being claims from an employer with operations in the province of Ontario, the screening officer found that the MSDSs in respect of which the claims were filed did not comply with the applicable disclosure requirements of the Occupational Health and Safety Act of the Province of Ontario.

In all cases where the MSDS or the label was determined not to be in compliance with the relevant legislation, the screening officer offered the claimant the possibility of entering into an undertaking whereby the claimant would voluntarily make the changes necessary to bring the MSDS or the label into compliance. Pursuant to subsection 16.1(1) of the Hazardous Materials Information Review Act, the claimant was given 30 days to provide the screening officer with a signed undertaking accompanied by the MSDS or the label amended as necessary.

In the case of the following claims, the claimant supplied the screening officer with a signed undertaking accompanied by the MSDS or label amended as necessary within the time frame specified. The screening officer was satisfied that the claimant had taken the measures set out in the undertaking in the manner and within the period specified therein.

CLAIMS FOR WHICH THE SCREENING OFFICER WAS SATISFIED THAT THE CLAIMANT HAD TAKEN THE MEASURES SET OUT IN THE UNDERTAKING

Pursuant to paragraph 18(1)(b) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Workplace Hazardous Materials Directorate hereby gives notice of any information that has been disclosed on the relevant MSDS or label in compliance with an undertaking.

Registry Number 8073

Date of notice confirming acceptance: December 17, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be washed with gently flowing water for at least 60 minutes.

  2. Disclose an LD50 (oral, male rat) value of 273 mg/kg for the hazardous ingredient “potassium hydroxide”.

  3. Disclose an LD50 (oral, rat) value of 5 119 mg/kg for the hazardous ingredient “dipropylene glycol monomethyl ether”.

  4. Disclose an LD50 (dermal, rabbit) value of 9 480 mg/kg for the hazardous ingredient “dipropylene glycol monomethyl ether”.

  5. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

Registry Number 8100

Date of notice confirming acceptance: March 12, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity of an additional hazardous ingredient “ethanol”, in the controlled product, together with its CAS registry number, in an acceptable manner.
  2. Disclose the ACGIH TLV–TWA Exposure Limit for the confidential hazardous ingredient “aldehyde” and show that “aldehyde” has been classified as a suspected human carcinogen (A2) by the American Conference of Governmental Industrial Hygienists (ACGIH).
  3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be rinsed continuously with gently flowing water for at least 30 minutes while holding the eyelids open.
  4. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  5. Disclose a statement to the effect that metal containers should be grounded during the transfer of large quantities of the controlled product; avoid or eliminate ignition sources when working with the controlled product and store the product away from ignition sources and heat, and that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source.
  6. Disclose an LD50 (dermal, rabbit) value of 2.03 mL/kg for the confidential hazardous ingredient “alcohol 2”.
  7. Disclose an LC50 (vapour, rat, 0.5 hours) value of 1 mg/L for the confidential hazardous ingredient “aldedyde”.
  8. Disclose that acute oral exposure to the hazardous ingredient “ethanol” in the controlled product has been shown to cause central nervous system (CNS) effects in humans.
  9. Disclose that acute oral exposure to the hazardous ingredients “ethanol” and “aldehyde” in the controlled product has been shown to cause adverse effects of the digestive system in laboratory animals.
  10. Disclose that acute inhalation of the confidential hazardous ingredient “aldehyde” in the controlled product has been shown to cause nasal cavity effects in laboratory animals.
  11. Disclose that chronic ingestion of the hazardous ingredient “ethanol” in the controlled product has been shown to cause adverse sperm, liver and heart effects in laboratory animals.
  12. Disclose that chronic ingestion of the confidential hazardous ingredient “alcohol 2” in the controlled product has been shown to cause adverse effects of the red blood cells in laboratory animals.
  13. Disclose that the confidential hazardous ingredient “aldehyde” in the controlled product has been shown to cause skin sensitization in laboratory animals.
  14. Disclose that the confidential hazardous ingredient “aldehyde” in the controlled product has been shown to cause adverse effects of the respiratory system in humans.
  15. Disclose the International Agency for Research on Cancer (IARC) Group 1 classification for the confidential hazardous ingredient “aldehyde”.
  16. Disclose that the confidential hazardous ingredient “aldehyde” in the controlled product has been shown to cause mutagenic effects in humans and animal cells, in vivo.
  17. Disclose that the hazardous ingredient “ethanol” in the controlled product has been shown to cause synergistic and potentiating effects with halogenated hydrocarbons and aldehydes in laboratory animals.
  18. Disclose that the hazardous ingredient “ethanol” in the controlled product has been shown to cause teratogenic and fetotoxic effects, in the presence of maternal toxicity, in humans.

Registry Number 8139

Date of notice confirming acceptance: November 6, 2012

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of four confidential hazardous ingredients “inorganic sulfate salt 1”, “inorganic sulfate salt 2”, “inorganic sulfate salt 3”, and “inorganic sulfate salt 4”, in the controlled product, together with their percent concentration, in an acceptable manner.

  2. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be washed with gently flowing water for at least 30 minutes.

  3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give plenty of water to drink.

  4. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.

  5. Disclose an ACGIH TLV–TWA Exposure Limit of 0.1 mg/m3 for the confidential hazardous ingredient “inorganic sulfate salt 4”.

  6. Add oxides of sulphur to the list of hazardous decomposition products.

  7. Disclose that the confidential hazardous ingredient “inorganic sulfate salt 4” in the controlled product has been shown to cause respiratory sensitization and has been shown to cause adverse effects of the respiratory system.

Registry Number 8173

Date of notice confirming acceptance: March 13, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

  2. Add oxides of sulphur and hydrogen chloride to the list of hazardous combustion products.

Registry Number 8181

Date of notice confirming acceptance: March 13, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that the confidential hazardous ingredient “oxygenated aromatic derivative” in the controlled product has been shown to cause skin sensitization in laboratory animals.

  2. Disclose an LD50 (oral, rat) value of 1 120 mg/kg for the confidential hazardous ingredient “oxygenated aromatic derivative”.

  3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that contaminated clothing, shoes and leather goods should be removed under running water and that medical attention must be obtained immediately.

  4. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects, in vitro, and teratogenic and fetotoxic effects in the absence of maternal toxicity in laboratory animals.

Registry Number 8184

Date of notice confirming acceptance: October 25, 2012

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product is corrosive to the eyes.

  2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be washed with gently flowing water for at least 30 minutes.

  3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that skin should be washed with gently flowing water for at least 20 minutes.

  4. Remove oxides of sulphur from the list of hazardous decomposition products.

  5. Disclose an LD50 (oral, rat) value of >500 mg/kg for the confidential hazardous ingredient “amine ethoxylate”.

Registry Number 8188

Date of notice confirming acceptance: November 27, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the percent concentrations for the confidential hazardous ingredients, “methylene phenylene isocyanate” and “diisocyanate polymer”, in the controlled product, in an acceptable manner.

  2. Add hydrogen chloride to the list of hazardous decomposition products.

Registry Number 8211

Date of notice confirming acceptance: November 27, 2012

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the percent concentrations for the confidential hazardous ingredients, “aliphatic urethane acrylate” and “acrylate ester”, in the controlled product, in an acceptable manner.

  2. Add hydrogen chloride to the list of hazardous combustion products.

Registry Number 8212

Date of notice confirming acceptance: November 27, 2012

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the percent concentrations for the confidential hazardous ingredients, “aliphatic urethane acrylate” and “acrylate ester”, in the controlled product, in an acceptable manner.

  2. Disclose the chemical identity of the confidential an additional hazardous ingredient, “xylene”, in the controlled product, together with its CAS registry number and percent concentration, in an acceptable manner.

Registry Number 8213

Date of notice confirming acceptance: November 27, 2012

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the percent concentrations for the confidential hazardous ingredients, “aliphatic urethane acrylate” and “acrylate ester”, in the controlled product, in an acceptable manner.

Registry Number 8214

Date of notice confirming acceptance: November 27, 2012

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the percent concentrations for the confidential hazardous ingredients, “aliphatic urethane acrylate” and “acrylate ester”, in the controlled product, in an acceptable manner.

Registry Number 8215

Date of notice confirming acceptance: November 27, 2012

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the percent concentrations for the confidential hazardous ingredients, “aliphatic urethane acrylate” and “acrylate ester”, in the controlled product, in an acceptable manner.

  2. Add hydrogen chloride to the list of hazardous combustion products.

Registry Number 8246

Date of notice confirming acceptance: March 5, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the percent concentrations for the confidential hazardous ingredients, “resin alkyd” and “resin acid ester polymer”, in the controlled product, in an acceptable manner.

  2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with gently flowing water for 20 minutes or until the chemical is removed.

  3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink.

  4. Disclose an LD50 (oral, female rat) value of 1 220 mg/kg for the hazardous ingredient “cobalt octoate”.

  5. Add oxides of nitrogen, oxides of sulphur and hydrogen chloride to the list of hazardous thermal decomposition products.

  6. Disclose that an ingredient in the controlled product is a skin irritant.

  7. Disclose the International Agency for Research on Cancer (IARC) Group 1 classification for one hazardous ingredient and Group 2B classification for two other hazardous ingredients.

  8. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.

Registry Number 8247

Date of notice confirming acceptance: January 7, 2013

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. If the WHMIS hazard symbols are displayed on the MSDS, disclose the appropriate hazard symbols for the product.

  2. Disclose the chemical identity of two additional hazardous ingredients, “fatty acid esters” and “amine borate mixture”, in the controlled product, together with their CAS registry numbers and percent concentration, in an acceptable manner.

Registry Number 8251

Date of notice confirming acceptance: January 17, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS and the content of the label. The claimant had been further advised to amend the MSDS as indicated below.

  1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A.

  2. Disclose an ACGIH TLV–STEL Exposure Limit of 150 ppm for the confidential hazardous ingredient “aromatic solvent 1”.

  3. Disclose an ACGIH TLV–STEL Exposure Limit of 250 ppm for the hazardous ingredient “methyl alcohol”.

  4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that medical attention must be obtained immediately.

  5. Disclose that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source.

  6. Disclose that the hazardous ingredient “methyl alcohol” in the controlled product has been shown to cause teratogenic effects in the absence of maternal toxicity.

Registry Number 8253

Date of notice confirming acceptance: January 17, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS and the content of the label. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an ACGIH TLV–STEL Exposure Limit of 150 ppm for the confidential hazardous ingredient “aromatic solvent 1”.

  2. Disclose an ACGIH TLV–STEL Exposure Limit of 250 ppm for the hazardous ingredient “methyl alcohol”.

  3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that medical attention must be obtained immediately.

  4. Disclose that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source.

  5. Disclose that the hazardous ingredient “methyl alcohol” in the controlled product has been shown to cause teratogenic effects in the absence of maternal toxicity.

Registry Number 8254

Date of notice confirming acceptance: March 5, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant has been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, female rat) value of 5 155 mg/kg for the hazardous ingredient “1-methyloxy-2-propyl acetate”.

  2. Disclose an LD50 (dermal, rabbit) value of 9.49 g/kg for the hazardous ingredient “ethyl 3-ethoxypropionate”.

  3. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in human and bacteria cells, in vitro.

Registry Number 8257

Date of notice confirming acceptance: April 16, 2013

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose inhalation as a route of exposure.

  2. Disclose the chemical identity of an additional hazardous ingredient, “methanol”, in the controlled product, together with its CAS registry number and the percent concentration in an acceptable manner.

  3. Disclose correct information concerning the proper storage conditions for the controlled product.

  4. Disclose an ACGIH TLV–TWA Exposure Limit of 200 ppm and an ACGIH TLV–STEL Exposure Limit of 250 ppm with skin notation for the hazardous ingredient “methanol”.

  5. Add oxides of nitrogen to the list of hazardous thermal decomposition products.

  6. Disclose a statement to the effect that contact of the controlled product with water should be avoided.

  7. Disclose oral and dermal LD50 values and an inhalation LC50 value for the confidential hazardous ingredient “organosilane ester” in an acceptable manner.

  8. Disclose that the confidential hazardous ingredient “organosilane ester” in the controlled product has been shown to cause skin sensitization in laboratory animals.

  9. Disclose that the hazardous ingredient “methanol” in the controlled product has been shown to cause teratogenic effects in the absence of maternal toxicity in laboratory animals.

Registry Number 8261

Date of notice confirming acceptance: December 3, 2012

The claimant had been advised to amend certain aspects of the format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be washed with gently flowing water for at least 30 minutes.

  2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement “dilute contents of stomach using 4–10 fluid ounces (120–300 mL) of milk or water”.

  3. In relation to the first aid information shown on the MSDS for ingestion, disclose advice to the effect that should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.

  4. Add oxides of carbon to the list of hazardous thermal decomposition products.

Registry Number 8267

Date of notice confirming acceptance: May 22, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the percent concentration for the confidential hazardous ingredient “ethoxylated alcohol”, in the controlled product, in an acceptable manner.

  2. Add oxides of carbon to the list of hazardous thermal decomposition products.

Registry Number 8271

Date of notice confirming acceptance: January 11, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity of an additional hazardous ingredient, “alcohols, C12-14-secondary, b-(2-hydroxyethoxy), ethoxylated”, in the controlled product, together with the percent concentration of 7%.

  2. Add oxides of carbon to the list of hazardous thermal decomposition products.

Registry Number 8278

Date of notice confirming acceptance: March 18, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the percent concentration for the confidential hazardous ingredient “inorganic salt 1”, in the controlled product, in an acceptable manner.

  2. Add oxides of sulphur to the list of hazardous decomposition products.

  3. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic and teratogenic effects and adverse reproductive effects in the absence of maternal toxicity in laboratory animals.

Registry Number 8279

Date of notice confirming acceptance: March 18, 2013

The claimant had been advised to amend certain aspects of the format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that the controlled product is an eye irritant.

  2. Disclose that the confidential hazardous ingredient “nitrate salt 2” is present in blood type AB.

  3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be washed with gently flowing water for at least 20 minutes or until the chemical is removed.

  4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give plenty of water to drink.

  5. Add oxides of nitrogen to the list of hazardous thermal decomposition products.

  6. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B.

Registry Number 8285

Date of notice confirming acceptance: March 25, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity of four additional hazardous ingredients, “alcohols, C10-16, ethoxylated propoxylated”, “fatty acids, C8-18 and C18-Unsat., compds. with isopropanolamine”, “fats and clyceridic oils, vegetable, polymd., oxidized”, and “2, 5-Furandione, dihydro-, monopolyisobutenyl dirvs., reaction products with triethanolamine”, in the controlled product, together with their CAS registry numbers and percent concentrations, in an acceptable manner.

  2. Disclose that an ingredient in the controlled product can be corrosive to the eyes.

  3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be rinsed continuously with gently flowing water for at least 30 minutes while holding the eyelids open and that medical attention must be obtained immediately.

  4. Disclose an LD50 (oral, rat) value of 4.26 g/kg and an LD50 (dermal, rabbit) value of 1.64 mL/kg for the confidential hazardous ingredient “monoisopropanolamine”.

Registry Number 8286

Date of notice confirming acceptance: January 22, 2013

The claimant had been advised to amend certain aspects of the format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity of two additional confidential hazardous ingredients, “polyolefin amide alkyleneamine, borated” and “long-chain hydrocardon”, in the controlled product, together with their percent concentrations, in an acceptable manner.

  2. Disclose an LD50 (oral, rat) value of >500 mg/kg for the confidential hazardous ingredient “long-chain alkenyl alkanol amide”.

Registry Number 8293

Date of notice confirming acceptance: January 7, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an ACGIH TLV–TWA Exposure Limit of 2 mg/m3 for the confidential hazardous ingredient “borate salt”.

  2. Disclose an LD50 (oral, rat) value of 1 660–3 350 mg/kg for the controlled product.

  3. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be flushed continuously with lukewarm, flowing water for 60 minutes, that contaminated clothing, shoes and leather goods should be removed under running water, and that medical attention must be obtained immediately.

  4. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.

  5. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give plenty of water or milk to drink.

Registry Number 8296

Date of notice confirming acceptance: November 19, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the percent concentration for the confidential hazardous ingredient “inorganic base”, in the controlled product, in an acceptable manner.

  2. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be washed with gently flowing water for at least 60 minutes.

  3. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.

  4. Disclose that chronic exposure to an ingredient in the product has been shown to cause adverse effects on the respiratory system.

Registry Number 8298

Date of notice confirming acceptance: January 30, 2013

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, rat) value of 1.0 g/kg and an LD50 (dermal, rat) value of 5.0 g/kg for the confidential hazardous ingredient “ethoxylated alcohol (1)”.

  2. Disclose an LD50 (oral, rat) value of 1.4 g/kg and an LD50 (dermal, rabbit) value of 2.0 g/kg for the confidential hazardous ingredient “ethoxylated alcohol (2)”.

Registry Number 8299

Date of notice confirming acceptance: January 7, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS.

Registry Number 8300

Date of notice confirming acceptance: January 7, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an ACGIH TVL–TWA Exposure Limit of 25 ppm for the hazardous ingredient “isobutyl ketone”.

Registry Number 8302

Date of notice confirming acceptance: February 28, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity of an additional confidential hazardous ingredient, “organic acid salt”, in the controlled product, together with its percent concentration, in an acceptable manner.

Registry Number 8303

Date of notice confirming acceptance: July 10, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of two additional confidential hazardous ingredients, “polyacrylamide polymer” and “mineral oil”, in the controlled product, together with their percent concentration, in an acceptable manner.

  2. Disclose an LD50 (oral, rat) value of 1 480 mg/kg and an LD50 (dermal, rabbit) value of 2 970 mg/kg for the confidential hazardous ingredient “ethoxylated nonyl phenol”.

  3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with gently flowing water for at least 20 minutes or until the chemical is removed and that contaminated clothing, shoes and leather goods should be removed under running water.

  4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water to drink.

  5. Disclose that exposure to an ingredient in the controlled product has been shown to cause teratogenic effects in the presence of maternal toxicity in laboratory animals.

Registry Number 8306

Date of notice confirming acceptance: December 17, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the percent concentration for the confidential hazardous ingredients “quarternary amide” and “alkoxylated alcohol”, in the controlled product, in an acceptable manner.

  2. Disclose the HMIRC registry number and date, in an acceptable manner.

Registry Number 8314

Date of notice confirming acceptance: October 25, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the HMIRC registry number and date, in an acceptable manner.

Registry Number 8315

Date of notice confirming acceptance: October 25, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the HMIRC registry number and date, in an acceptable manner.

  2. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that medical attention must be obtained immediately.

Registry Number 8320

Date of notice confirming acceptance: March 13, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause liver effects in laboratory animals.

  2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed gently with water for 20 minutes.

  3. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped and that medical attention must be obtained immediately.

  4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water to drink.

  5. Add oxides of nitrogen and hydrogen chloride to the list of hazardous decomposition products.

  6. Disclose an LD50 (oral, rat) value of >500 mg/kg and an LD50 (dermal, rabbit) value of >1 000 mg/kg for the confidential hazardous ingredient “alkyl glycol”.

  7. Disclose an LD50 (oral, rat) value of >500 mg/kg, an LD50 (dermal, rabbit) value of >1 000 mg/kg and an LC50 (vapour, female rat, 4 hours) value of >2 500 ppm for the confidential hazardous ingredient “alcohol 2”.

  8. Disclose an LD50 (oral, rat) value of >500 mg/kg for the confidential hazardous ingredient “sodium alkylbenzenesulfonate”.

  9. Disclose that ingestion of the confidential hazardous ingredient “alkyl glycol” has been shown to cause kidney and neurological effects in humans.

  10. If the WHMIS classifications are stated on the MSDS, disclose the B2 classification.

Registry Number 8322

Date of notice confirming acceptance: December 3, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed continuously with lukewarm, flowing water for 20 minutes and that medical attention must be obtained immediately.

  2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.

  3. Disclose that under conditions of reduced ventilation that use of an approved National Institute for Occupational Safety and Health (NIOSH) organic vapour respirator respiratory is recommended.

  4. Disclose an LD50 (oral, rat) value of 798.1 mg/kg for the controlled product.

Registry Number 8334

Date of notice confirming acceptance: January 8, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that artificial respiration or cardiopulmonary resuscitation should be administered immediately if breathing has stopped or the heart has stopped.

Registry Number 8335

Date of notice confirming acceptance: January 8, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8344

Date of notice confirming acceptance: January 7, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that acute ingestion and inhalation of an ingredient in the controlled product has been shown to cause low blood pressure and central nervous system (CNS) effects in both humans and laboratory animals.

  2. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.

  3. Add oxides of nitrogen and oxides of sulphur to the list of hazardous combustion products.

  4. Disclose that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire if they contact an ignition source.

  5. Disclose that an ingredient in the controlled product is incompatible with chromium trioxide.

Registry Number 8345

Date of notice confirming acceptance: January 7, 2013

The claimant had been advised to amend certain aspects of the content and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Add oxides of nitrogen to the list of hazardous decomposition products.

Registry Number 8346

Date of notice confirming acceptance: March 5, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the percent concentration for the confidential hazardous ingredient, “alkyl glycoside (2)”, in the controlled product, in an acceptable manner.

Registry Number 8348

Date of notice confirming acceptance: January 2, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8350

Date of notice confirming acceptance: October 16, 2012

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give plenty of water to drink.

Registry Number 8354

Date of notice confirming acceptance: March 28, 2013

The claimant had been advised to amend certain aspects of the format of the MSDS.

Registry Number 8358

Date of notice confirming acceptance: January 28, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that medical attention must be obtained immediately.

  2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.

Registry Number 8360

Date of notice confirming acceptance: January 28, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of an additional confidential hazardous ingredient, “modified epoxy resin”, in the controlled product, together with its percent concentration, in an acceptable manner.

  2. Disclose the presence of two additional hazardous ingredients, “decabromodiphenyl oxide” and “silica siliconized”, in the controlled product, together with their CAS registry numbers and percent concentrations, in an acceptable manner.

  3. Disclose an LC50 (rat, 4 hours) value of 315–708 mg/m3 for the hazardous ingredient “silica siliconized”.

Registry Number 8364

Date of notice confirming acceptance: January 22, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that if the casualty is rapidly losing consciousness, convulsing or is unconscious, vomiting should not be induced and fluids should not be offered to drink.

  2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that medical attention must be obtained immediately.

Registry Number 8365

Date of notice confirming acceptance: October 15, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8366

Date of notice confirming acceptance: November 21, 2012

The claimant had been advised to amend certain aspects of the content and format of the MSDS.

Registry Number 8369

Date of notice confirming acceptance: January 30, 2013

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product can be corrosive to the eyes and skin.

  2. Disclose that acute and chronic oral, skin and inhalation exposure to an ingredient in the controlled product has been shown to cause blood cell destruction in laboratory animals.

  3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be rinsed continuously with gently flowing water for at least 30 minutes and that medical attention must be obtained immediately.

  4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed continuously with lukewarm, flowing water for 30 minutes, that contaminated clothing, shoes and leather goods should be removed under running water and that medical attention must be obtained immediately.

  5. Disclose that the hazardous ingredient “butyl glycol ether” has been classified as a suspected human carcinogen (A3) by the American Conference of Governmental Industrial Hygienists (ACGIH).

  6. Disclose that inhalation of an ingredient in the controlled product has been shown to cause fetotoxic effects in the presence of maternal toxicity in laboratory animals.

  7. If the WHMIS classifications and pictograms are stated on the MSDS, disclose that the controlled product is also in class E and disclose the E pictogram.

Registry Number 8370

Date of notice confirming acceptance: December 11, 2012

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that acute and chronic oral, skin and inhalation exposure to an ingredient in the controlled product has been shown to cause blood cell damage in laboratory animals.

  2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with gently flowing water for 20 minutes or until the chemical is removed.

  3. Disclose that the hazardous ingredient “butyl glycol ether” has been classified as a suspected human carcinogen (A3) by the American Conference of Governmental Industrial Hygienists (ACGIH).

Registry Numbers 8393, 8394, 8395, 8396, 8397 and 8398

Date of notice confirming acceptance: January 8, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Numbers 8399, 8400, 8401, 8402, 8403, 8404, 8405, 8406 and 8407

Date of notice confirming acceptance: December 21, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8408

Date of notice confirming acceptance: March 6, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity of an additional confidential hazardous ingredient, “substituted polyolefin amide alkeneamine”, in the controlled product, together with its percent concentration, in an acceptable manner.

  2. Disclose an LD50 (oral, rat) value of 510 mg/kg and an LD50 (dermal, rabbit) value of 1.9 g/kg for the confidential hazardous ingredient “alkaryl polyether”.

Registry Number 8412

Date of notice confirming acceptance: December 5, 2012

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that medical attention must be obtained immediately.

  2. In relation to the first aid information shown on the MSDS for skin contact and ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with gently flowing water for 20 minutes or until the chemical is removed.
  4. Disclose that the hazardous ingredient “formaldehyde” has been classified as a suspected human carcinogen (A2) by the American Conference of Governmental Industrial Hygienists (ACGIH).
  5. Disclose that the hazardous ingredient, “phenol” in the controlled product has been shown to cause mutagenic effects in animal cells and bacteria, in the absence and/or presence of metabolic activation, in vitro.

Registry Number 8415

Date of notice confirming acceptance: August 8, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that artificial respiration or cardiopulmonary resuscitation should be administered immediately if breathing has stopped or the heart has stopped.
  2. Disclose an AIHA WEEL–TWA value of 10 mg/m3 for the hazardous ingredient “diethylene glycol”.

Registry Number 8418

Date of notice confirming acceptance: February 27, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that skin should be washed with gently flowing water for at least 30 minutes and that medical attention must be obtained immediately.
  2. Add oxides of carbon to the list of hazardous decomposition products.

Registry Number 8419

Date of notice confirming acceptance: June 18, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the percent concentration for the hazardous ingredient “crystalline silica (quartz)”, in the controlled product, in an acceptable manner.
  2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed continuously with lukewarm, flowing water for 60 minutes.
  3. Add oxides of carbon to the list of hazardous combustion products.

Registry Number 8423

Date of notice confirming acceptance: February 11, 2013

The claimant had been advised to amend certain aspects of the format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that acute dermal exposure to the hazardous ingredient “heavy aromatic naphtha” in the controlled product has been shown to cause central nervous system (CNS) effects in laboratory animals.
  2. Disclose an LC50 (female rat, 4 hours) value of 1.72 mg/L for the confidential hazardous ingredient “hydrocarbon”.

Registry Number 8424

Date of notice confirming acceptance: March 13, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. If the WHMIS classifications and pictograms are stated on the MSDS, disclose that the controlled product is also in class D1A and the D1A pictogram.
  2. Disclose the generic chemical identity of an additional confidential hazardous ingredient, “aliphatic alcohol”, in the controlled product, together with its percent concentration, in an acceptable manner.
  3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be rinsed continuously with gently flowing water for at least 30 minutes.
  4. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that vomiting should not be induced, medical attention must be obtained immediately and that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  5. Disclose an ACGIH TLV–STEL Exposure Limit of 15 ppm with a skin notation for the confidential hazardous ingredient “alcohol solvent”.
  6. Disclose an ACGIH TLV–TWA Exposure Limit of 200 ppm and an ACGIH TLV–STEL Exposure Limit of 250 ppm for the confidential hazardous ingredient “aliphatic alcohol”.
  7. Add oxides of carbon and oxides of nitrogen to the list of hazardous thermal decomposition products.
  8. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause central nervous system (CNS) effects in humans.
  9. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause liver effects in laboratory animals.
  10. Disclose an LD50 (oral, rat) value and an LC50 (vapour, rat 4 hours) value for the confidential hazardous ingredient “alcohol solvent”, in an acceptable manner.
  11. Disclose an LD50 (oral, rat) value and an LD50 (dermal, rabbit) value for the confidential hazardous ingredient “sugar alcohol”, in an acceptable manner.
  12. Disclose an LD50 (oral, guinea pig) value of 260 mg/kg and an LC50 (vapour, rat, 4 hours) value of 300 ppm for the hazardous ingredient “formaldehyde”, in an acceptable manner.
  13. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects, in vivo and in vitro.
  14. Disclose that an ingredient in the controlled product has been classified Group 1 by the International Agency for Research on Cancer (IARC).
  15. Disclose that ingredients in the controlled product have been shown to cause teratogenic and embryotoxic/fetotoxic effects in laboratory animals.

Registry Number 8425

Date of notice confirming acceptance: March 13, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be flushed continuously with flowing water for 30 minutes and that medical attention must be obtained immediately.
  2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.
  3. Add oxides of carbon and oxides of nitrogen to the list of hazardous thermal decomposition products.

Registry Number 8426

Date of notice confirming acceptance: April 9, 2013

The claimant had been advised to amend certain aspects of the wording of the MSDS.

Registry Number 8427

Date of notice confirming acceptance: January 13, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that medical attention must be obtained immediately.
  2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two to four cups of water or milk.

  3. Add oxides of carbon to the list of hazardous combustion/ decomposition products.

Registry Number 8439

Date of notice confirming acceptance: August 6, 2013

The claimant had been advised to amend certain aspects of the format of the MSDS.

Registry Number 8442

Date of notice confirming acceptance: August 6, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS.

Registry Number 8446

Date of notice confirming acceptance: April 15, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose a statement to the effect that the eyes and skin should be flushed continuously with flowing water for 60 minutes.
  2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to dilute contents of stomach using 4–10 fluid ounces (120–300 mL) of water or milk.
  3. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.
  4. Add oxides of carbon, nitrogen and sulphur, and hydrogen chloride to the list of hazardous thermal decomposition products.

Registry Number 8454

Date of notice confirming acceptance: May 27, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with lukewarm, flowing water for 30 minutes and that medical attention must be obtained immediately.
  2. Add oxides of nitrogen and hydrogen chloride to the list of hazardous combustion products.
  3. Disclose an LD50 (oral, rat) value of >500 mg/kg for the confidential hazardous ingredient “organic acid”.
  4. Disclose that the confidential hazardous ingredient “organic acid” in the controlled product has been shown to cause eye corrosion in laboratory animals.

Registry Numbers 8455, 8456 and 8457

Date of notice confirming acceptance: May 27, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed continuously with lukewarm, flowing water for 30 minutes.
  2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.
  3. Add oxides of nitrogen and hydrogen chloride to the list of hazardous combustion products.
  4. Disclose an LD50 (oral, rat) value and an LC50 (vapour, rat, 4 hours) value for the confidential hazardous ingredient “organic acid”, in an acceptable manner.

Registry Number 8459

Date of notice confirming acceptance: March 27, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8462

Date of notice confirming acceptance: April 23, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Add oxides of nitrogen to the list of hazardous combustion products.
  2. Disclose that the confidential hazardous ingredient “fatty acids” in the controlled product is a skin sensitizer.

Registry Number 8463

Date of notice confirming acceptance: March 6, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of an additional confidential hazardous ingredient, “long-chain carboxylic acid alkanolamine compound”, in the controlled product, together with its percent concentration, in an acceptable manner.

Registry Number 8465

Date of notice confirming acceptance: March 6, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity of an additional hazardous ingredient, “diethanolamine”, in the controlled product, together with its percent concentration, in an acceptable manner.
  2. Disclose that an ingredient in the controlled product has been classified in Group 2B by the International Agency for Research on Cancer (IARC).
  3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 8467

Date of notice confirming acceptance: April 15, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of an additional hazardous ingredient, “aliphatic carboxylic acids”, in the controlled product, together with its CAS registry number and percent concentration, in an acceptable manner.

Registry Number 8468

Date of notice confirming acceptance: August 2, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects, in vitro.
  2. Disclose the generic chemical identity of two additional confidential hazardous ingredients, “propoxylated polyethylenepolyamine #1” and “propoxylated polyethylenepolyamine #2”, in the controlled product, together with their percent concentration, in an acceptable manner.
  3. Add oxides of nitrogen to the list of hazardous combustion products.
  4. Disclose an AIHA WEEL–TWA Exposure Limit of 1 ppm with a skin notation for the confidential hazardous ingredient “polyethylenepolyamine”.
  5. Disclose an ACGIH Exposure Limit with a skin notation for the confidential hazardous ingredient “propoxylated polyethylenepolyamine #1”.

Registry Number 8470

Date of notice confirming acceptance: July 29, 2013

The claimant had been advised to amend certain aspects of the format of the MSDS.

Registry Number 8483

Date of notice confirming acceptance: January 14, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have casualty lean forward in order to reduce the risk of aspiration.

Registry Number 8485

Date of notice confirming acceptance: March 25, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  2. Disclose an LD50 (oral, rat) value of 239.9 mg/kg for the confidential hazardous ingredient “quaternary ammonium compound”.

Registry Number 8487

Date of notice confirming acceptance: July 10, 2013

The claimant had been advised to amend certain aspects of the format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of an additional confidential hazardous ingredient, “substituted aliphatic amine”, in the controlled product, together with its percent concentration, in an acceptable manner.
  2. Disclose an LD50 (oral, rat) value of >5 000 mg/kg for the hazardous ingredient “petroleum naphtha”.

Registry Number 8488

Date of notice confirming acceptance: July 10, 2013

The claimant had been advised to amend certain aspects of the format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of an additional confidential hazardous ingredient, “substituted aliphatic amine”, in the controlled product, together with its percent concentration, in an acceptable manner.
  2. Disclose an LD50 (oral, rat) value of >5 000 mg/kg for the hazardous ingredient “petroleum naphtha”.

Registry Number 8489

Date of notice confirming acceptance: July 10, 2013

The claimant had been advised to amend certain aspects of the format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, rat) value of >5 000 mg/kg for the hazardous ingredient “petroleum naphtha”.

Registry Numbers 8497 and 8501

Date of notice confirming acceptance: May 1, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose that the confidential hazardous ingredient “substituted alkylamine” in the controlled product has been shown to cause eye corrosion in laboratory animals.
  2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be washed with gently flowing water for at least 30 minutes.
  3. Disclose an AIHA WEEL–TWA Exposure Limit of 100 ppm for the confidential hazardous ingredient “aliphatic alcohol(1)”.
  4. Disclose an ACGIH TVL–TWA Exposure Limit of 100 ppm and an ACGIH TVL–STEL Exposure Limit of 125 ppm for the confidential hazardous ingredient “aliphatic alcohol(2)”.
  5. Disclose that the confidential hazardous ingredient “substituted alkylamine” in the controlled product has been shown to cause mutagenic effects in bacterial cells.

Registry Number 8509

Date of notice confirming acceptance: January 25, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.

Registry Number 8517

Date of notice confirming acceptance: January 30, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS.

Registry Number 8518

Date of notice confirming acceptance: January 30, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Add oxides of sulphur to the list of hazardous decomposition products.

Registry Number 8521

Date of notice confirming acceptance: April 15, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose inhalation as a route of exposure.
  2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that medical attention must be obtained immediately.
  3. Disclose that the confidential hazardous ingredient “alkylphenol ethoxylate” in the controlled product has been shown to cause teratogenic effects in the presence of maternal toxicity in laboratory animals.

Registry Number 8522

Date of notice confirming acceptance: April 23, 2013

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, rat) value of >500 mg/kg for the confidential hazardous ingredient “diol ester”.

Registry Number 8523

Date of notice confirming acceptance: March 28, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose inhalation as a route of exposure.
  2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that contaminated clothing, shoes and leather goods should be removed under running water.
  3. Disclose that the confidential hazardous ingredient “Bis(2-dimethylaminoethyl)ether (BDMAEE)” in the controlled product has been shown to cause skin corrosion in rabbits.
  4. Disclose that the confidential hazardous ingredient “Bis(2-dimethylaminoethyl)ether (BDMAEE)” in the controlled product has been shown to cause teratogenic effects, in the presence of maternal toxicity, in laboratory animals.

Registry Numbers 8527 and 8528

Date of notice confirming acceptance: May 1, 2013

The claimant had been advised to amend certain aspects of the wording of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, male rat) value of >500 mg/kg and an LD50 (dermal, rabbit) value of >1 000 mg/kg for the confidential hazardous ingredient “ketone (2)”.

Registry Number 8540

Date of notice confirming acceptance: May 27, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.

Registry Number 8591

Date of notice confirming acceptance: June 18, 2013

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  2. Disclose that an ingredient in the controlled product is incompatible with chromium trioxide.
  3. Disclose an LD50 (oral, rat) value of 3 000 mg/kg for the confidential hazardous ingredient “branched alkylphenol, ethoxylate”.

Registry Number 8592

Date of notice confirming acceptance: May 1, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that the confidential hazardous ingredient “inorganic acid” in the controlled product has been shown to cause teratogenic/embryotoxic effects, in the absence of maternal toxicity, in laboratory animals.

Registry Number 8593

Date of notice confirming acceptance: June 18, 2013

The claimant had been advised to amend certain aspects of the content and format of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient in the controlled product is incompatible with potassium.
  2. Disclose that the confidential hazardous ingredient “inorganic acid” in the controlled product has been shown to cause teratogenic/embryotoxic effects, in the absence of maternal toxicity, in laboratory animals.

Registry Number 8626

Date of notice confirming acceptance: April 2, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. Add oxides of nitrogen and oxides of sulphur to the list of hazardous thermal decomposition products.

Registry Number 8630

Date of notice confirming acceptance: February 18, 2013

The claimant had been advised to amend certain aspects of the content of the MSDS. The claimant had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed continuously with lukewarm, flowing water for 20 minutes and that medical attention must be obtained immediately.
  2. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects, in vitro.

In the case of the following claims, either the claimant did not supply the screening officer with a signed undertaking or the screening officer was not satisfied that the claimant had taken the measures set out in the undertaking in the manner and within the period specified in it. Pursuant to subsection 17(1) of the Hazardous Materials Information Review Act, the screening officer ordered the claimant to comply with the requirements of the relevant legislation within 30 days from the expiry of the appeal period, except that the information in respect of which the claim for exemption was made does not have to be disclosed, and to provide a copy of the amended MSDS to the screening officer within 40 days of expiry of the appeal period.

CLAIMS FOR WHICH THE SCREENING OFFICER ORDERED THE CLAIMANT TO COMPLY WITH THE APPLICABLE DISCLOSURE REQUIREMENTS

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Workplace Hazardous Materials Directorate hereby gives notice of any information that the screening officer ordered to be disclosed on an MSDS or a label reviewed by the screening officer.

Registry Number 8124

Date of order: December 11, 2012

The claimant has been ordered to amend certain aspects of the content, format and wording of the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of five additional confidential hazardous ingredients, “phosphoric acid”, “oxo alcohol (A)”, “oxo alcohol (B)”, “glycol ether” and “organo phosphorous compound”, in the controlled product, together with their percent concentrations, in an acceptable manner.
  2. Disclose an LD50 (oral, mouse) value of >500 mg/kg for the confidential hazardous ingredient “oxo alcohol (A)”.
  3. Disclose an LD50 (oral, rat) value of >500 mg/kg for the confidential hazardous ingredient “oxo alcohol (B)”.
  4. Disclose an LD50 (oral, rat) value of >500 mg/kg and an LD50 (dermal, rabbit) value of >1 000 mg/kg for the confidential hazardous ingredient “glycol ether”.
  5. Disclose an LD50 (oral, male rat) value of >500 mg/kg and an LC50 (aerosol, rat, 1 hour) value of >2.5 mg/L for the confidential hazardous ingredient “organo phosphorous compound”.
  6. Disclose an AIHA WEEL–TWA Exposure Limit of 50 ppm for the confidential hazardous ingredient “oxo alcohol (A)”.
  7. Disclose an ACGIH TVL–TWA Exposure Limit of 2.2 mg/m3 for the confidential hazardous ingredient “organo phosphorous compound”.
  8. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause urinary bladder and liver effects in laboratory animals.
  9. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause postnatal and fetotoxic effects in the presence of maternal toxicity in laboratory animals.

Registry Number 8270

Date of order: July 23, 2013

The claimant has been ordered to amend certain aspects of the wording of the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

  1. Disclose that oral exposure to the hazardous ingredient “benzyl alcohol” in the controlled product has been shown to cause central nervous system (CNS) effects in laboratory animals.
  2. Disclose that the hazardous ingredient “benzyl alcohol” in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.
  3. Disclose the generic chemical identity of an additional confidential hazardous ingredient, “cycloaliphatic amine adduct”, in the controlled product, in an acceptable manner.
  4. Disclose an AIHA WEEL–TWA value of 10 ppm for the hazardous ingredient “benzyl alcohol”.
  5. Add oxides of carbon, oxides of nitrogen and hydrogen chloride to the list of hazardous combustion products.
  6. Disclose an LD50 (oral, rat) value of 1 230 mg/kg for the hazardous ingredient “benzyl alcohol”.

Registry Number 8274

Date of order: July 23, 2013

The claimant has been ordered to amend certain aspects of the content and wording of the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of the confidential hazardous ingredient “alkyl alkoxylated epoxide”, in the controlled product, in an acceptable manner.
  2. Disclose the presence of an additional hazardous ingredient, “propanol, 1 (or 2)- ethoxy”, in the controlled product, together with its percent concentration, in an acceptable manner.
  3. Add oxides of carbon, oxides of nitrogen and hydrogen chloride to the list of hazardous combustion products.
  4. Disclose an ACGIH TLV–TWA Exposure Limit of 100 mg/m3 (ceiling) for the hazardous ingredient “ethylene glycol”.
  5. Disclose that ingestion of the hazardous ingredient “ethylene glycol” in the controlled product has been shown to cause teratogenic effects in the absence of maternal toxicity, in laboratory animals.

Note: The following claims, 8158, 8275 and 8416, were cancelled after the issuance of the decisions; thus, neither a signed undertaking was provided nor was an order issued. The screening officer has identified the following instances of non-compliance with the requirements of the relevant legislation.

Registry Number 8158

The screening officer determined that amendments to the MSDS were required as indicated below.

  1. Disclose an LC50 (aerosol, male rat) value of 1.72 mg/L for the hazardous ingredient “distillates (petroleum), hydrotreated light”.
  2. Disclose a lower LD50 (dermal, rabbit) value of 2 764 mg/kg for the hazardous ingredient “diethylene glycol monobutyl ether”.
  3. Disclose an LD50 (oral, rat) value of 5.3 g/kg for the hazardous ingredient “triethylene glycol butyl ether”.
  4. Disclose three additional confidential hazardous ingredients, “9,12-octadecadienamide, N,N-bis(2-hydroxyethyl)-”, “diethanolamine” and “fatty acids, tall oil”, in the controlled product, together with their CAS registry numbers and percent concentrations, in an acceptable manner.
  5. Disclose an LD50 (oral, rat) value of 10.5 g/kg for the hazardous ingredient “9,12-octadecadienamide, N,N-bis(2-hydroxyethyl)-”.
  6. Disclose an ACGIH TLV–TWA Exposure Limit of 1 mg/m3 (skin) for the hazardous ingredient “diethanolamine”.
  7. Disclose that an ingredient in the controlled product has been classified Group 2B by the International Agency for Research on Cancer (IARC).
  8. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in the presence of metabolic activation, in vitro.
  9. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 8275

The screening officer determined that amendments to the MSDS were required as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed gently with water for 20 minutes.
  2. Disclose an AIHA WEEL–TWA value of 25 ppm for the confidential hazardous ingredient “glycol ether”.
  3. Disclose an ACGIH TLV–STEL Exposure Limit of 150 ppm for the hazardous ingredient “dipropylene glycol methyl ether”.
  4. Disclose an LD50 (dermal, female rabbit) value of 8.48 g/kg for the confidential hazardous ingredient “glycol ether”.
  5. Disclose an LD50 (dermal, male rabbit) value of 9.48 g/kg for the confidential hazardous ingredient “dipropylene glycol methyl ether”.
  6. Disclose that ingestion of and dermal exposure to an ingredient in the controlled product have been shown to cause central nervous system (CNS) effects in laboratory animals.
  7. Disclose that dermal exposure of an ingredient in the controlled product has been shown to cause kidney effects.

Registry Number 8416

The screening officer determined that amendments to the MSDS were required as indicated below.

  1. Disclose that the confidential hazardous ingredient “fatty acid” in the controlled product is a skin sensitizer.
  2. Disclose the chemical identity of two additional confidential hazardous ingredients, “9-octadecenoic acid (9Z)-, compound with 2-aminoethanol” and “phosphoric acid, 2-ethylhexyl ester, compound with 2-aminoethanol”, in the controlled product, together with their CAS registry numbers and percent concentrations, in an acceptable manner.
  3. Disclose an OSHA TLV–STEL Exposure Limit of 150 ppm for the confidential hazardous ingredient “glycol ether”.

[38-1-o]

DEPARTMENT OF INDUSTRY

OFFICE OF THE REGISTRAR GENERAL

Appointments
Name and position Order in Council
Bracken, The Hon. Keith 2013-912
Government of British Columbia  
Administrator  
September 16 to September 20, 2013  
Fréchette, Jean-Denis 2013-903
Parliamentary Budget Officer  
Government of Ontario 2013-909
Administrators  
Hoy, The Hon. Alexandra H.  
September 23 and from December 10 to December 20, 2013  
Lauwers, The Hon. Peter D.  
September 1 to September 6, 2013  
Rosenberg, The Hon. Marc  
September 17 to September 20, 2013  
Smith, The Hon. Heather J.  
September 30 to October 6, 2013, and from December 21, 2013, to January 5, 2014  
Government of Saskatchewan 2013-910
Administrators  
Cameron, The Hon. Stuart J.  
October 7 to October 10, 2013  
Lane, The Hon. J. Gary  
September 30 to October 2, 2013  
Ottenbreit, The Hon. Ralph K.  
September 7 and September 8, 2013  
Murphy, The Hon. Michele M. 2013-911
Government of Prince Edward Island  
Administrator  
September 14 to October 4, 2013  
Proulx, Fernand 2013-907
National Museum of Science and Technology  
Acting Director  
Tedesco, Lucie 2013-908
Financial Consumer Agency of Canada  
Commissioner  
Usher, Marlene 2013-906
Enterprise Cape Breton Corporation  
Acting Chief Executive Officer  

September 13, 2013

DIANE BÉLANGER
Official Documents Registrar

[38-1-o]

DEPARTMENT OF INDUSTRY

OFFICE OF THE REGISTRAR GENERAL

Appointments

Name and position

Instrument of Advice dated September 3, 2013

Carignan, The Hon. Claude

Queen’s Privy Council for Canada

Member

September 13, 2013

DIANE BÉLANGER
Official Documents Registrar

[38-1-o]

DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS

CRIMINAL CODE

Revocation of designation as fingerprint examiner

Pursuant to subsection 667(5) of the Criminal Code, I hereby revoke the designation of the following persons of the Royal Newfoundland Constabulary as fingerprint examiners:

Lester Parsons

Karl Piercey

Ottawa, September 9, 2013

KATHY THOMPSON
Assistant Deputy Minister
Law Enforcement and Policing Branch

[38-1-o]

OFFICE OF THE SUPERINTENDENT OF FINANCIAL INSTITUTIONS

BANK ACT

B2B Bank — Letters patent of amalgamation and order to commence and carry on business

Notice is hereby given of the issuance,

  • pursuant to subsection 229(1) of the Bank Act, of letters patent amalgamating and continuing B2B Bank and AGF Trust Company as one bank under the name in English, B2B Bank and in French, B2B Banque, effective on September 1, 2013; and
  • pursuant to subsection 48(4) of the Bank Act, of an order to commence and carry on business authorizing B2B Bank to commence and carry on business, effective on the date on which the letters patent of amalgamation become effective.

August 21, 2013

JULIE DICKSON
Superintendent of Financial Institutions

[38-1-o]

OFFICE OF THE SUPERINTENDENT OF FINANCIAL INSTITUTIONS

BANK ACT

Santander Consumer USA Inc. — Approval to have a financial establishment in Canada

Notice is hereby given, pursuant to subsection 522.211(1) of the Bank Act, that the Minister of Finance approved, on August 6, 2013, Santander Consumer USA Inc. to have a financial establishment in Canada.

August 21, 2013

JULIE DICKSON
Superintendent of Financial Institutions

[38-1-o]